Clinical trial of thread embedding acupuncture for facial nerve palsy sequelae
- Conditions
- Diseases of the nervous system
- Registration Number
- KCT0008551
- Lead Sponsor
- Kyung Hee University Oriental Medicine Hospital at Gangdong
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 142
1) Adults between the ages of 19 and 70
2) Peripheral facial palsy more than 12 months after onset
3) 80 points or less in a total score by the Sunnybrook Facial Grading System
4) Synkinesis in more than one facial region by the Sunnybrook Facial Grading System
5) Not receiving any treatment for the peripheral facial palsy sequelae within the last month
6) Voluntary participation with written consent after hearing an explanation of the clinical trial
1) Thread embedding acupuncture or botox treatment on the face within the last three months
2) Hypersensitivity to electroacupuncture or thread embedding acupuncture, metal allergy, severe keloid skin, and other skin sensitivities
3) Bilateral peripheral facial palsy sequelae
4) Facial nerve paralysis due to tumor or cerebrovascular disease
5) History of surgical treatment for the facial nerve, including facial nerve decompression
6) Skin diseases or blood clotting disorders for which thread embedding acupuncture is contraindicated
7) Pregnant or planning to become pregnant
8) Mental illness or inability to communicate in compliance with clinical trials
9) Other reasons judged unsuitable by the researcher
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Physical function score of Facial Disability Index
- Secondary Outcome Measures
Name Time Method Social/Well-being function score of Facial Disability Index;Sunnybrook Facial Grading System;Synkinesis Assessment Questionnaire;Numeric Rating Scale of stiffness by facial region;Patient Global Impression of Change;Euro-Qol 5-Dimention 5-Level;Economic evaluation questionnaire;Adverse events